| Filed On | Filing |
|---|---|
| 21 Apr 2022 | Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other |
| 09 Nov 2021 |
Form 3: Kuriakose Emil, CHIEF MEDICAL OFFICER
Holds 60,467 shares of Common Stock |
| 14 Jul 2020 |
Form 3: Garland J. Scott, Director
Holds 0 shares of No securities beneficially owned |
| 01 Jul 2019 |
Form 3: Bvf Partners L P/IL, 10% owner and 6 others
Holds 3,288,378 shares of Common Stock, $0.0001 par value |
| 03 Oct 2017 |
Form 3: Ray Sumita, See Remarks
Holds 0 shares of No securities beneficially owned |
| 21 Sep 2017 |
Form 3: Wise Blake, Director
Holds 0 shares of No securities beneficially owned |
| 06 Jan 2017 |
Form 3: Wong Stephanie, VP, FINANCE
Holds 14,102 shares of Common Stock |
| 06 Jan 2017 |
Form 3: Parlati Francesco, VP, RESEARCH
Holds 12,382 shares of Common Stock |
| 11 Aug 2016 |
Form 3: Jones Suzy, Director
Holds 7,197 shares of Common Stock |
| 03 May 2016 |
Form 3: Orford Keith, SR. VP, CLINICAL DEVELOPMENT
Holds 2,120 shares of Common Stock |
| 30 Sep 2015 |
Form 3: Agarwal Sunil, Director
Holds 0 shares of No securities beneficially owned |
| 09 Dec 2014 |
Form 3: Wolff Henry Ward, Director
Holds 0 shares of No securities beneficially owned |
| 01 Oct 2014 | Form 3: Advanced Technology Ventures Viii Lp, 10% owner and 1 other |
| 01 Oct 2014 | Form 3: Delphi Management Partners VIII, L.l.c., 10% owner and 6 others |
| 01 Oct 2014 | Form 3: Pakianathan Deepika, Director |
| 01 Oct 2014 | Form 3: Drachman Jonathan G, Director |
| 01 Oct 2014 |
Form 3: Sjogren Eric, SR. VP, DRUG DISCOVERY
Holds 11,631 shares of COMMON STOCK |
| 01 Oct 2014 |
Form 3: Hecht Curtis, VP, BUS. & CORP. DEVELOPMENT
Holds 4,125 shares of COMMON STOCK |
| 01 Oct 2014 |
Form 3: Molineaux Susan, Director
Holds 106,962 shares of Common Stock |
| 01 Oct 2014 |
Form 3: Molineaux Christopher, SR. VP, DRUG DEVELOPMENT
Holds 106,962 shares of Common Stock |
Loading...
